Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy.

Frangou E, Varnavidou-Nicolaidou A, Petousis P, Soloukides A, Theophanous E, Savva I, Michael N, Toumasi E, Georgiou D, Stylianou G, Mean R, Anastasiadou N, Athanasiou Y, Zavros M, Kyriacou K, Deltas C, Hadjianastassiou V.

Nephrol Dial Transplant. 2019 Oct 1;34(10):1780-1788. doi: 10.1093/ndt/gfz021.

PMID:
30844074
2.

Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant.

Vernon KA, Gale DP, de Jorge EG, McLean AG, Galliford J, Pierides A, Maxwell PH, Taube D, Pickering MC, Cook HT.

Am J Transplant. 2011 Jan;11(1):152-5. doi: 10.1111/j.1600-6143.2010.03333.x. Epub 2010 Nov 29.

3.

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.

Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, Zavros M, Maxwell PH, Cook HT, Demosthenous P, Hadjisavvas A, Kyriacou K, Zouvani I, Pierides A, Deltas C.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1436-46. doi: 10.2215/CJN.09541010. Epub 2011 May 12.

4.

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.

Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC.

Lancet. 2010 Sep 4;376(9743):794-801. doi: 10.1016/S0140-6736(10)60670-8. Epub 2010 Aug 25.

5.

A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.

Medjeral-Thomas N, Malik TH, Patel MP, Toth T, Cook HT, Tomson C, Pickering MC.

Kidney Int. 2014 Apr;85(4):933-7. doi: 10.1038/ki.2013.348. Epub 2013 Sep 25.

6.

C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.

Deltas C, Gale D, Cook T, Voskarides K, Athanasiou Y, Pierides A.

Adv Exp Med Biol. 2013;735:189-96. Review.

PMID:
23402027
7.

Regulating complement in the kidney: insights from CFHR5 nephropathy.

Gale DP, Pickering MC.

Dis Model Mech. 2011 Nov;4(6):721-6. doi: 10.1242/dmm.008052. Review.

8.

Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy.

Zhai YL, Meng SJ, Zhu L, Shi SF, Wang SX, Liu LJ, Lv JC, Yu F, Zhao MH, Zhang H.

J Am Soc Nephrol. 2016 Sep;27(9):2894-905. doi: 10.1681/ASN.2015010012. Epub 2016 Jan 29.

9.

A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl.

Besbas N, Gulhan B, Gucer S, Korkmaz E, Ozaltin F.

J Nephrol. 2014 Aug;27(4):457-60. doi: 10.1007/s40620-013-0008-1. Epub 2013 Dec 5.

PMID:
24536001
10.

C3 glomerulonephritis and CFHR5 nephropathy.

Gale DP, Maxwell PH.

Nephrol Dial Transplant. 2013 Feb;28(2):282-8. doi: 10.1093/ndt/gfs441. Epub 2012 Nov 2. Review.

PMID:
23125424
11.

C3 Glomerulopathy.

Martín B, Smith RJH.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2007 Jul 20 [updated 2018 Apr 5].

12.

Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.

Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM.

Am J Kidney Dis. 2017 Dec;70(6):770-777. doi: 10.1053/j.ajkd.2017.06.024. Epub 2017 Aug 16.

PMID:
28821363
13.

Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.

Ng YS, Vathsala A, Chew ST, Chiang GS, Woo KT.

Med J Malaysia. 2007 Jun;62(2):109-13.

14.

Higher Incidence of Renal Allograft Glomerulonephritis in Living-Related Donor Kidney Transplantation.

Deng R, Dai Y, Zhang H, Liu L, Li J, Xiong Y, Deng S, Fu Q, Wang C.

Transplant Proc. 2018 Oct;50(8):2421-2425. doi: 10.1016/j.transproceed.2018.03.050. Epub 2018 Mar 15.

PMID:
30316370
15.

Recurrent IgA nephropathy in renal transplant allografts.

Wang AY, Lai FM, Yu AW, Lam PK, Chow KM, Choi PC, Lui SF, Li PK.

Am J Kidney Dis. 2001 Sep;38(3):588-96.

PMID:
11532693
16.

Favorable outcome of renal transplantation in patients with IgA nephropathy.

Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.

Clin Nephrol. 2001 Oct;56(4):279-88.

PMID:
11680657
17.

Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.

Sawada A, Kawanishi K, Horita S, Koike J, Honda K, Ochi A, Komoda M, Tanaka Y, Unagami K, Okumi M, Shimizu T, Ishida H, Tanabe K, Nagashima Y, Nitta K.

Nephrology (Carlton). 2016 Jul;21 Suppl 1:48-52. doi: 10.1111/nep.12775. Review.

PMID:
26971743
18.

Single-center long-term results of renal transplantation for IgA nephropathy.

Bumgardner GL, Amend WC, Ascher NL, Vincenti FG.

Transplantation. 1998 Apr 27;65(8):1053-60.

PMID:
9583865
19.

C3 glomerulopathy.

Servais A, Noël LH, Frémeaux-Bacchi V, Lesavre P.

Contrib Nephrol. 2013;181:185-93. doi: 10.1159/000348654. Epub 2013 May 8. Review.

PMID:
23689580
20.

Recurrent Glomerulonephritis in Renal Transplantation: Experience in Our Renal Transplantation Center.

Cañas L, López D, Pérez JF, Bancu I, Juega J, Ariza A, Bonet J, Lauzurica R.

Transplant Proc. 2015 Oct;47(8):2354-6. doi: 10.1016/j.transproceed.2015.08.024.

PMID:
26518925

Supplemental Content

Support Center